Are we Headed for a Pandemic Redux?
Amid cases of measles, H5N1, and Mpox, a weakened public health infrastructure and anti-science sentiment could result in a pandemic redux.
Category: Emerging & Zoonotic Diseases
Emerging & Zoonotic Diseases
Latest
Emerging & Zoonotic Diseases
Latest
Abbott Survey Reveals Gaps in Pandemic Preparedness
Abbott's Pandemic Preparedness Survey found significant gaps remain in surveillance programs and testing infrastructure capabilities.
Emerging & Zoonotic Diseases
Latest
P. Vivax Malaria Biomarkers Associated with Recurrence Identified
Brazilian researchers identified potential biomarkers linked to the recurrence of P. vivax malaria, providing insights for drug development.
Researchers Identify Hantavirus Through New Rapid Test to Curb Potential Outbreaks
A study showcased the application of Flongle sequencing as a cost-efficient and rapid method to detect the zoonotic pathogen.
Read More
How Disease Surveillance Will Help Spot Disease X
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read More
Black Individuals More Likely to Experience Inequities in Lyme Disease Diagnosis
A new study has revealed disparities in the diagnosis and treatment of Lyme disease between Black and White patients with the condition.
Read More
Self-Sampling Proves Effective for Asymptomatic Mpox Diagnosis
A pilot study demonstrated the importance of self-sampling in diagnosing asymptomatic or atypical cases of mpox.
Read More
Scientists Find Flaw in Malaria Diagnostics
Current diagnostic methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood.
Read More
New Mpox Rapid Test is Adaptable for Other Diseases
A rapid test for mpox has been developed that can detect the virus within minutes, without the use of any high-end instrumental techniques.
Read More
Startup Gets $1 Million Grant to Build Infectious Disease Breathalyzer
Noze received a grant of $1 million to build a breathalyzer, powered by its platform, to detect breath biomarkers (VOCs).
Read More
Cue Health’s Molecular Mpox Test Gets FDA EUA
Cue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read More
Virax Biolabs Unveils Avian Influenza A Virus PCR Test
The test kit is for use in laboratory settings and can help healthcare professionals accurately identify an Avian Influenza A Virus infection.
Read More
Cepheid’s Mpox Test Gets Emergency Use Authorization
The FDA issued an emergency use authorization for the Cepheid Xpert Mpox (monkeypox) test for use in a point-of-care setting.
Read More
New Approach to Overcome Lyme Disease Diagnosis Challenges Gets Validation
A new study identified Raman spectroscopy as a promising diagnostic approach for Lyme disease, according to the Bay Area Lyme Foundation.
Read More
Microbix Launches Quality Assessment Product to Support Mpox Testing
Microbix Biosystems is launching a new quality assessment product to support molecular diagnostic testing for the non-variola orthopoxvirus.
Read More
BD, CerTest Biotec Mpox Test Gets Emergency Use Authorization
BD and CerTest Biotec have announced EUA from the U.S. Food and Drug Administration (FDA) for a molecular PCR assay for Mpox virus detection.
Read More
Dissecting Limitations and Challenges of Mpox Testing
Clinical labs learned about the limitations of mpox testing during last summer’s outbreak, taking away valuable lessons.
Read More
The Urban and Rural Differences in Monkeypox Testing and Vaccination
The CDC has urged the public to engage in monkeypox testing & vaccination efforts as well as mitigate behaviors to prevent the virus’ spread.
Read More